Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
J Dermatol ; 48(4): 551-555, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33369759

RESUMEN

The in vitro microbicidal activity of benzoyl peroxide against Cutibacterium acnes, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Malassezia furfur, Malassezia restricta, and Malassezia globosa was investigated. These strains were incubated for 1 h in the presence of 0.25, 0.5, 1, or 2 mmol/L benzoyl peroxide in phosphate buffered saline supplemented with 0.1% glycerol and 2% Tween 80. After exposure to benzoyl peroxide, counts of viable Gram-positive bacteria and fungi were markedly decreased, whereas counts of Gram-negative bacteria were unchanged. Transmission electron microscopy images showed a decrease in electron density and the destruction of C. acnes and M. restricta cell walls after exposure to 2 mmol/L benzoyl peroxide. In conclusion, this study showed that benzoyl peroxide has a potent and rapid microbicidal activity against Gram-positive bacteria and fungi that are associated with various cutaneous diseases. This suggests that the direct destruction of bacterial cell walls by benzoyl peroxide is an essential mechanism of its rapid and potent microbicidal activity against microorganisms.


Asunto(s)
Peróxido de Benzoílo , Propionibacterium acnes , Malassezia , Pruebas de Sensibilidad Microbiana
2.
J Dermatol Sci ; 98(1): 50-57, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32284168

RESUMEN

BACKGROUND: Amenamevir (AMNV) is a helicase-primase inhibitor with antiviral activity against herpesviruses [herpes simplex viruses (HSV)-1 and -2, and varicella-zoster virus], which are associated with the development of acute herpetic pain (AHP) and postherpetic neuralgia. However, the inhibitory effects of helicase-primase inhibitors on AHP and postherpetic neuralgia remain incompletely understood. OBJECTIVE: In this study, we investigated the effects of AMNV on AHP and postherpetic pain (PHP) in HSV-1-infected mice accompanied by zosteriform-like skin lesions. METHODS: HSV-1 was percutaneously infected on the femoral region of mice. AMNV was orally administered twice a day for 5 days. Pain-related response in the hind paw was evaluated using a paintbrush. The infiltration of inflammatory cells in dorsal root ganglion (DRG) and spinal cord (SC) was evaluated by hematoxylin and eosin staining. The viral load in DRG and the expression of pain-related genes in SC were measured by real-time PCR. RESULTS: Pain response was begun to be observed from day 3 post-infection (pi) in HSV-1-infected mice. AMNV administered repeatedly from day 3 pi or day 4 pi, but not day 5 pi, showed an inhibitory effect on the development of AHP and the transition to PHP. Repeated AMNV administration inhibited inflammatory cell infiltration and increases in the viral load and the expression of pain-related genes (ATF-3, TNF-α, COX-2). CONCLUSION: These results demonstrate that AMNV potently suppresses the development of AHP and the transition to PHP as a consequence of decreased viral load in DRG and reduced expression of pain-related genes in SC.


Asunto(s)
Dolor Agudo/tratamiento farmacológico , Antivirales/administración & dosificación , Herpes Simple/tratamiento farmacológico , Neuralgia Posherpética/tratamiento farmacológico , Oxadiazoles/administración & dosificación , Dolor Agudo/inmunología , Dolor Agudo/virología , Administración Oral , Animales , Modelos Animales de Enfermedad , Femenino , Herpes Simple/complicaciones , Herpes Simple/inmunología , Herpes Simple/virología , Herpesvirus Humano 1/inmunología , Herpesvirus Humano 1/aislamiento & purificación , Humanos , Ratones , Neuralgia Posherpética/inmunología , Neuralgia Posherpética/virología , Carga Viral/efectos de los fármacos , Carga Viral/inmunología
3.
Mycoses ; 63(2): 189-196, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31724251

RESUMEN

BACKGROUND: Lanoconazole (LCZ) is a topical antifungal agent clinically used to treat fungal infections such as tinea pedis. LCZ has not only antifungal effects but also anti-inflammatory effects, which have the potential to provide additional clinical benefits. However, the characteristic features of the inhibitory effects of LCZ on skin inflammation remain unclear. OBJECTIVE: We evaluated the inhibitory effects of topical application of LCZ, and compared the effects of LCZ with those of other antifungal agents including liranaftate, terbinafine and amorolfine. METHODS: Each antifungal agent was topically applied on 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis and 2,4,6-trinitrophenyl chloride-induced contact dermatitis in mice (BALB/c). The ear thickness, myeloperoxidase activity and inflammatory mediator contents were evaluated. RESULTS: LCZ dose-dependently suppressed 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis, suppressed the production of neutrophil chemotactic factors such as keratinocyte-derived chemokine and macrophage inflammatory protein-2, and inhibited neutrophil infiltration to the inflammation site. Moreover, 1% LCZ reduced the ear swelling in mice with 2,4,6-trinitrophenyl chloride-induced contact dermatitis in accordance with the inhibition of interferon-γ production. The inhibitory potency of LCZ on these types of dermatitis in mice was stronger than that of other types of antifungal agents. CONCLUSION: The anti-inflammatory effects of LCZ were exerted through the inhibition of inflammatory mediator production. These effects may contribute to the relief of dermatitis symptoms in patients with tinea pedis.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Dermatitis por Contacto/tratamiento farmacológico , Imidazoles/uso terapéutico , Picratos/efectos adversos , Acetato de Tetradecanoilforbol/efectos adversos , Tiña del Pie/patología , Animales , Antifúngicos/uso terapéutico , Dermatitis por Contacto/etiología , Dermatitis por Contacto/prevención & control , Relación Dosis-Respuesta a Droga , Oído Externo/efectos de los fármacos , Oído Externo/patología , Femenino , Ratones , Ratones Endogámicos BALB C , Tiña del Pie/complicaciones
4.
Am J Pathol ; 181(5): 1540-59, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22959908

RESUMEN

We investigated human cytomegalovirus pathogenesis by comparing infection with the low-passage, endotheliotropic strain VR1814 and the attenuated laboratory strain AD169 in human placental villi as explants in vitro and xenografts transplanted into kidney capsules of SCID mice (ie, mice with severe combined immunodeficiency). In this in vivo human placentation model, human cytotrophoblasts invade the renal parenchyma, remodel resident arteries, and induce a robust lymphangiogenic response. VR1814 replicated in villous and cell column cytotrophoblasts and reduced formation of anchoring villi in vitro. In xenografts, infected cytotrophoblasts had a severely diminished capacity to invade and remodel resident arteries. Infiltrating lymphatic endothelial cells proliferated, aggregated, and failed to form lymphatic vessels. In contrast, AD169 grew poorly in cytotrophoblasts in explants, and anchoring villi formed normally in vitro. Likewise, viral replication was impaired in xenografts, and cytotrophoblasts retained invasive capacity, but some partially remodeled blood vessels incorporated lymphatic endothelial cells and were permeable to blood. The expression of both vascular endothelial growth factor (VEGF)-C and basic fibroblast growth factor increased in VR1814-infected explants, whereas VEGF-A and soluble VEGF receptor-3 increased in those infected with AD169. Our results suggest that viral replication and paracrine factors could undermine vascular remodeling and cytotrophoblast-induced lymphangiogenesis, contributing to bleeding, hypoxia, and edema in pregnancies complicated by congenital human cytomegalovirus infection.


Asunto(s)
Vasos Sanguíneos/fisiopatología , Infecciones por Citomegalovirus/patología , Citomegalovirus/fisiología , Linfangiogénesis , Placentación , Trofoblastos/patología , Trofoblastos/virología , Animales , Arterias/patología , Vasos Sanguíneos/patología , Movimiento Celular , Proliferación Celular , Vellosidades Coriónicas/crecimiento & desarrollo , Vellosidades Coriónicas/patología , Vellosidades Coriónicas/trasplante , Vellosidades Coriónicas/virología , Infecciones por Citomegalovirus/congénito , Infecciones por Citomegalovirus/fisiopatología , Infecciones por Citomegalovirus/virología , Células Endoteliales/metabolismo , Células Endoteliales/patología , Femenino , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Humanos , Riñón/irrigación sanguínea , Riñón/patología , Ratones , Ratones SCID , Embarazo , Células Madre/patología , Células Madre/virología , Regulación hacia Arriba , Factor A de Crecimiento Endotelial Vascular/metabolismo , Factor C de Crecimiento Endotelial Vascular/metabolismo , Replicación Viral
5.
Circ J ; 76(6): 1442-51, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22473458

RESUMEN

BACKGROUND: The aim of the present study was to assess the effects of angiotensin II receptor blocker (ARB) on coronary plaque progression in patients with acute myocardial infarction (AMI) who received an angiotensin-converting enzyme inhibitor (ACEI). METHODS AND RESULTS: After local ethics committee approval and obtaining of informed consent, 116 patients with AMI were randomly assigned to receive a combination of valsartan and captopril or captopril alone. Non-culprit intermediate coronary atherosclerosis was assessed on intravascular ultrasound. The primary and secondary endpoints were the nominal change in percent atheroma volume (PAV) and percent change in lumen volume (%ΔLV), respectively. The combination group had a significantly lower systolic blood pressure (117 vs. 125 mmHg; P=0.02) and a lower plasma aldosterone level (56 vs. 75 pg/ml; P=0.02) at follow-up. The nominal change in PAV was slightly lower in the combination group than in the ACEI group (-1.9 vs. -0.68%, P=0.06). %ΔLV was -0.3% in the ACEI group and was 4.3% in the combination group (P=0.03). Logistic regression analysis showed that additional ARB therapy was independently associated with LV enlargement (odds ratio, 2.144; 95% confidence interval: 1.818-5.618; P=0.03). CONCLUSIONS: In this study of patients with AMI, additional ARB therapy had minimal impact on the progression of coronary atherosclerosis as compared with an ACEI alone. The combination of these 2 drugs, however, induces coronary artery enlargement.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Antihipertensivos/uso terapéutico , Presión Sanguínea/efectos de los fármacos , Captopril/uso terapéutico , Enfermedad de la Arteria Coronaria/tratamiento farmacológico , Infarto del Miocardio/tratamiento farmacológico , Sistema Renina-Angiotensina/efectos de los fármacos , Tetrazoles/uso terapéutico , Valina/análogos & derivados , Anciano , Aldosterona/sangre , Bloqueadores del Receptor Tipo 1 de Angiotensina II/efectos adversos , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Antihipertensivos/efectos adversos , Biomarcadores/sangre , Captopril/efectos adversos , Distribución de Chi-Cuadrado , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/fisiopatología , Quimioterapia Combinada , Femenino , Humanos , Hipertrofia Ventricular Izquierda/fisiopatología , Hipertrofia Ventricular Izquierda/prevención & control , Japón , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Infarto del Miocardio/sangre , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/fisiopatología , Oportunidad Relativa , Valor Predictivo de las Pruebas , Estudios Prospectivos , Medición de Riesgo , Factores de Riesgo , Tetrazoles/efectos adversos , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía Intervencional , Valina/efectos adversos , Valina/uso terapéutico , Valsartán
6.
J Electrocardiol ; 45(3): 285-7, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22217367

RESUMEN

There are few reports of acute myocardial infarction (AMI) relating to the occlusion of the conus branch, most of which are iatrogenic in nature. So far as we are concerned, this is the first case of spontaneous AMI with isolated conus branch occlusion. Electrocardiogram (ECG) showed mild elevation of ST segment in leads V(1) through V(3). Cardiac makers of myocardial infarction were positive. Right coronary angiography revealed an isolated occlusion of the conus branch. Penetration of the guidewire in the occluded lesion was attempted, and recanalization was successfully achieved. The patient was discharged without any adverse events.


Asunto(s)
Oclusión Coronaria/complicaciones , Oclusión Coronaria/diagnóstico , Electrocardiografía/métodos , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/etiología , Anciano , Diagnóstico Diferencial , Humanos , Masculino
7.
J Cardiol Cases ; 5(1): e39-e43, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30532899

RESUMEN

BACKGROUND: We report a rare case of acute pulmonary embolism (PE) induced by urinary retention and bladder distention with benign prostatic hyperplasia (BPH). CASE REPORT: A 76-year-old male with BPH presented to the hospital with anuria of 24 h duration and abdominal distention. Physical examination revealed tenderness and distention of the lower abdomen and a swollen right leg. Echocardiography after urethral catheterization showed a large free-floating thrombus traversing back and forth through the tricuspid orifice. Computed tomographic angiography demonstrated filling defects at the level of the right inter lobar pulmonary artery and the segmental branches of both pulmonary arteries, indicating acute PE. The patient was treated with heparin and warfarin for three weeks to ensure the resolution of the pulmonary embolus. After the resolution of all symptoms, the patient was discharged without further complication. CONCLUSION: This case suggested that a distended bladder is a potential risk factor for the development of deep vein thrombosis and PE.

8.
Am J Pathol ; 177(3): 1298-310, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20651234

RESUMEN

Human cytomegalovirus (HCMV) is the major viral cause of birth defects worldwide. Affected infants can have temporary symptoms that resolve soon after birth, such as growth restriction, and permanent disabilities, including neurological impairment. Passive immunization of pregnant women with primary HCMV infection is a promising treatment to prevent congenital disease. To understand the effects of sustained viral replication on the placenta and passive transfer of protective antibodies, we performed immunohistological analysis of placental specimens from women with untreated congenital infection, HCMV-specific hyperimmune globulin treatment, and uninfected controls. In untreated infection, viral replication proteins were found in trophoblasts and endothelial cells of chorionic villi and uterine arteries. Associated damage included extensive fibrinoid deposits, fibrosis, avascular villi, and edema, which could impair placental functions. Vascular endothelial growth factor and its receptor fms-like tyrosine kinase 1 (Flt1) were up-regulated, and amniotic fluid contained elevated levels of soluble Flt1 (sFlt1), an antiangiogenic protein, relative to placental growth factor. With hyperimmune globulin treatment, placentas appeared uninfected, vascular endothelial growth factor and Flt1 expression was reduced, and sFlt1 levels in amniotic fluid were lower. An increase in the number of chorionic villi and blood vessels over that in controls suggested compensatory development for a hypoxia-like condition. Taken together the results indicate that antibody treatment can suppress HCMV replication and prevent placental dysfunction, thus improving fetal outcome.


Asunto(s)
Vellosidades Coriónicas/virología , Infecciones por Citomegalovirus/metabolismo , Placenta/virología , Trofoblastos/virología , Proteínas Virales/metabolismo , Análisis de Varianza , Vellosidades Coriónicas/metabolismo , Vellosidades Coriónicas/patología , Citomegalovirus , Infecciones por Citomegalovirus/patología , Infecciones por Citomegalovirus/virología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunohistoquímica , Placenta/metabolismo , Placenta/patología , Embarazo , Trofoblastos/metabolismo , Trofoblastos/patología , Factor A de Crecimiento Endotelial Vascular/metabolismo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo
9.
Circ J ; 74(7): 1384-91, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20467155

RESUMEN

BACKGROUND: Monocytes and macrophages have been shown to play major roles in the progression of atherosclerosis. This study examined whether the circulating monocyte count can be used to predict coronary plaque progression of non-culprit intermediate lesions in acute myocardial infarction (AMI). METHODS AND RESULTS: Intravascular ultrasound findings of non-culprit intermediate plaque in 90 patients were analyzed in the acute phase and at a 7-month follow up. A higher peak monocyte count after AMI was associated with a greater plaque volume change (r=0.32, P=0.002). Multivariate analysis showed that a peak monocyte count of > or =800 /mm(3) was an independent predictor of plaque progression (odds ratio 5.02, P=0.005). High monocyte (> or =800 /mm(3)) at baseline had a higher monocyte count at 7-month follow up than did those with a lower count (368+/-109 vs 263+/-64 /mm(3), P<0.0001). Moreover, the monocyte count at the 7-month follow up was also associated with plaque volume change (r=0.29, P=0.006). CONCLUSIONS: The results suggest that circulating monocytes play an important role in the progression of coronary plaque in AMI and that the peak monocyte count during hospitalization might be a predictor of plaque progression.


Asunto(s)
Enfermedad de la Arteria Coronaria/diagnóstico , Monocitos/patología , Infarto del Miocardio/diagnóstico por imagen , Valor Predictivo de las Pruebas , Anciano , Recuento de Células Sanguíneas , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Observación , Ultrasonografía Intervencional
10.
J Clin Virol ; 46 Suppl 4: S58-63, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19854676

RESUMEN

BACKGROUND: Cytomegalovirus (CMV) is the major cause of congenital infection and disease leading to permanent birth defects. In about 35-40% of pregnant women with primary CMV infection, virus crosses the placenta, resulting in the birth of congenitally infected babies. In contrast, this happens in only 1-3% of seropositive women with strong CMV-specific humoral immunity. Whether CMV reaches the fetus and disseminates depends on the level of high-avidity antibodies in the maternal circulation and the passive immunity of the fetus. OBJECTIVES AND STUDY DESIGN: To identify CMV infection in uncomplicated deliveries based on detection of viral DNA in placental biopsy specimens at term. To quantify CMV-specific IgG avidity, neutralizing titer, IgG1 concentration, and characterize the immunoblot profiles for CMV proteins in paired samples of placental and cord blood sera. RESULTS: In accord with earlier reports, CMV DNA was detected in 39% (11/28) of placentas with mean- to high-avidity CMV-specific IgG. In seropositive women, the concentration of antiviral antibodies, specifically IgG1, increased in the fetal bloodstream, and CMV neutralizing titers in maternal and fetal blood were comparable. CONCLUSIONS: CMV-specific, high-avidity neutralizing antibodies from maternal circulation are transcytosed to the fetal bloodstream, contribute to suppression of viral replication in the placenta and could prevent congenital disease.


Asunto(s)
Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Infecciones por Citomegalovirus/inmunología , Citomegalovirus/inmunología , Feto/inmunología , Inmunoglobulina G/sangre , Complicaciones Infecciosas del Embarazo/inmunología , Afinidad de Anticuerpos/inmunología , Infecciones por Citomegalovirus/sangre , Femenino , Sangre Fetal/inmunología , Sangre Fetal/virología , Feto/virología , Humanos , Transmisión Vertical de Enfermedad Infecciosa , Pruebas de Neutralización , Placenta/inmunología , Placenta/virología , Embarazo , Complicaciones Infecciosas del Embarazo/sangre , Complicaciones Infecciosas del Embarazo/virología
11.
Virology ; 391(1): 99-106, 2009 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-19559454

RESUMEN

We reported previously that the guinea pig cytomegalovirus (CMV) stock purchased from the American Type Culture Collection contained two types of strains, one containing and the other lacking a 1.6 kb locus, and that the 1.6 kb locus was required for efficient viral growth in animals but not in cell culture. In this study, we characterized the genetic contents of the locus, and found that i) the 1.6 kb locus encodes homologs of human CMV UL128 and UL130, GP129 and GP131, respectively, ii) these genes are expressed with late gene kinetics, iii) GP131 protein (pGP131) localized to cell surface only in the presence of glycoproteins H and L, and iv) pGP131 is a virion component. Therefore, it is plausible that pGP131 forms a complex with glycoproteins H and L and becomes a virion component as does UL130 protein (pUL130). Since pUL130 is one of the glycoproteins essential for infection of endothelial and epithelial cells in human and primates, functional and immunological analyses of this GPCMV homolog of pUL130 may help to illuminate the in vivo role of pUL130.


Asunto(s)
Genes Inmediatos-Precoces , Glicoproteínas de Membrana/genética , Roseolovirus/genética , Proteínas del Envoltorio Viral/genética , Secuencia de Aminoácidos , Animales , Células Cultivadas , ADN Viral/genética , Femenino , Genoma Viral , Cobayas , Datos de Secuencia Molecular , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido
12.
Virology ; 379(1): 45-54, 2008 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-18656220

RESUMEN

Guinea pig cytomegalovirus (GPCMV) provides a useful model for studies of congenital CMV infection. During characterization of the GPCMV genome sequence, we identified two types of strains in a virus stock purchased from ATCC. One of them, GPCMV/del, lacks a 1.6 kb locus that positionally corresponds to murine CMV (MCMV) M129-M133. Growth of GPCMV/del in cell culture was marginally better than that of the other strain, GPCMV/full, which harbors the 1.6 kb locus. However, in animals infected intraperitoneally with virus stocks containing both strains, GPCMV/full disseminated more efficiently than GPCMV/del, including 200-fold greater viral load in salivary glands. Viral DNA, transcripts of the immediate-early 2 gene homolog, and viral antigens were more abundant in animals infected with GPCMV/full than in those infected with GPCMV/del. Although the observed phenomena have some similarity with the growth properties of MCMV strains defective in mck-1/mck-2(M129/131) and those defective in sgg(M132), no M129-M132 homologs were found in the 1.6 kb locus. Since one of the ORFs in the locus has a weak sequence similarity with HCMV UL130, which relates to cell tropism, further studies will be required to learn the mechanism for efficient GPCMV growth in animal.


Asunto(s)
Roseolovirus/crecimiento & desarrollo , Roseolovirus/patogenicidad , Eliminación de Secuencia , Replicación Viral , Animales , Antígenos Virales/biosíntesis , Técnicas de Cultivo de Célula , Línea Celular , ADN Viral/biosíntesis , ADN Viral/química , ADN Viral/genética , Genoma Viral , Cobayas , Hígado/patología , Datos de Secuencia Molecular , Filogenia , ARN Viral/biosíntesis , Roseolovirus/genética , Infecciones por Roseolovirus/virología , Glándulas Salivales/virología , Análisis de Secuencia de ADN , Homología de Secuencia , Bazo/patología , Ensayo de Placa Viral
13.
J Am Coll Cardiol ; 50(13): 1230-7, 2007 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-17888839

RESUMEN

OBJECTIVES: We sought to assess whether coronary plaque rupture at culprit lesions is associated with infarct size in patients with anterior acute myocardial infarction (AMI). BACKGROUND: Some patients with AMI have large infarcts despite early reperfusion. Whether culprit plaque morphology impacts infarct size or not remains unknown. METHODS: Patients who had a first anterior AMI with reperfusion within 6 hours after onset were enrolled and divided into 2 groups according to the presence or absence of plaque rupture at the culprit lesion as defined by preintervention intravascular ultrasound (IVUS): patients with rupture (n = 54) and without rupture (n = 37). RESULTS: Patients with plaque rupture had a higher incidence of no-reflow phenomenon (15% vs. 3%; p = 0.08) and a lower myocardial blush grade (1.5 vs. 2.3; p < 0.05) after percutaneous coronary intervention. The IVUS analysis showed that patients with plaque rupture had a higher incidence of soft plaque and positive remodeling. Peak creatine kinase levels were higher (4,707 vs. 2,309 IU/l; p < 0.0001) and left ventricular ejection fraction in the chronic phase was lower (54% vs. 63%; p < 0.01) in patients with plaque rupture. A multivariate logistic regression analysis revealed that plaque rupture and the proximal lesion site correlated with a left ventricular ejection fraction of <50% in the chronic phase (odds ratios 6.5 and 17.5, respectively; p < 0.05). CONCLUSIONS: Plaque rupture is associated with morphologic characteristics of vulnerable lesions, as well as with larger infarcts and a higher incidence of no-reflow phenomenon, suggesting that plaque embolism contributes to the progression of myocardial damage in patients with anterior AMI.


Asunto(s)
Enfermedad de la Arteria Coronaria/patología , Infarto del Miocardio/patología , Angioplastia Coronaria con Balón , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/terapia , Creatina Quinasa/sangre , Electrocardiografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Infarto del Miocardio/terapia , Reperfusión Miocárdica , Rotura Espontánea/patología , Volumen Sistólico , Ultrasonografía Intervencional , Remodelación Ventricular
14.
Virus Genes ; 35(3): 571-5, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17694428

RESUMEN

The UL11 and UL51 gene products of herpes simplex virus (HSV) are membrane-associated tegument proteins that are incorporated into the HSV virion. UL11 and UL51 are conserved throughout the herpesvirus family. Both UL11 and UL51, either singly or in combination, are involved in virion envelopment and/or egress. Both proteins are fatty acylated: UL11 is both acylated by myristoic and palmitoic acids and UL51 is monoacylated by palmitoic acid. Using confocal microscopy and sucrose gradient fractionations in transfected or HSV-infected cells, we found that HSV-2 UL11 but not UL51 was associated with lipid rafts. The dual acylation of UL11 was necessary for lipid raft association, as mutations in the myristoylation or palmitoylation sites prevented lipid raft association. These differences in lipid raft association may contribute to the functional differences between UL11 and UL51.


Asunto(s)
Microdominios de Membrana/química , Simplexvirus/fisiología , Proteínas Estructurales Virales/análisis , Acilación , Animales , Fraccionamiento Celular , Línea Celular , Centrifugación por Gradiente de Densidad , Chlorocebus aethiops , Perros , Humanos , Microscopía Confocal , Unión Proteica , Procesamiento Proteico-Postraduccional
15.
J Infect Dis ; 195(6): 782-8, 2007 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-17299707

RESUMEN

BACKGROUND: Sensorineural hearing loss (SNHL) is the most common congenital disease. Longitudinal studies of infants with congenital cytomegalovirus (CMV) infection have demonstrated an association between CMV and SNHL. However, because of the lack of suitable neonatally collected specimens, the proportion of CMV-associated SNHL has not been defined, nor has the relationship between CMV and the major genetic causes of SNHL, such as mutations in the GJB2 gene. METHODS: Sixty-seven children with severe SNHL were analyzed for CMV and human herpesvirus 6 (HHV-6) infections and for GJB2 mutations. DNA specimens were prepared from dried umbilical cords, which are available for everyone born in Japan. Four children with typical symptomatic infection at birth served as positive control subjects. RESULTS: Congenital CMV infection and GJB2 mutations were identified in 15% and 24% of the patients, respectively. HHV-6 was not detected. All children with CMV-associated cases developed SNHL before they were 2 years old. Most children with CMV-associated SNHL had no obvious clinical abnormality at birth, and their viral loads were lower than those of symptomatic children. CONCLUSIONS: Congenital CMV infection is an important cause of severe SNHL, and it has an incidence comparable to that of GJB2-associated SNHL.


Asunto(s)
Conexinas/genética , Infecciones por Citomegalovirus/epidemiología , Citomegalovirus/aislamiento & purificación , Pérdida Auditiva Sensorineural/etiología , Mutación , Secuencia de Bases , Conexina 26 , ADN/sangre , ADN/genética , ADN/aislamiento & purificación , Cartilla de ADN , Femenino , Sangre Fetal/química , Predisposición Genética a la Enfermedad , Pérdida Auditiva Sensorineural/genética , Pruebas Auditivas , Herpesvirus Humano 6/aislamiento & purificación , Humanos , Recién Nacido , Masculino
16.
J Clin Microbiol ; 45(4): 1305-7, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17287318

RESUMEN

Since congenital cytomegalovirus (CMV) infection causes late-onset sequelae, the identification of CMV-infected newborns is important. For this purpose, we established a simple real-time PCR assay using a filter disk. Combined with the collection of urine using filter papers placed in the diaper, this assay can make CMV screening more feasible and cost-effective.


Asunto(s)
Infecciones por Citomegalovirus/diagnóstico , Citomegalovirus/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Orina/virología , Virología/métodos , Citomegalovirus/genética , ADN Viral/análisis , ADN Viral/genética , Humanos , Lactante , Recién Nacido
17.
Microbes Infect ; 9(2): 183-91, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17208485

RESUMEN

Cytomegalovirus infects fetuses through the placenta, resulting in various congenital disorders in newborns, including hearing loss. We developed a monoclonal antibody to guinea pig cytomegalovirus (GPCMV) that was available for immunohistochemistry, and investigated the expression of the GPCMV antigen in animal models of direct and congenital infections. Injection of GPCMV, directly to the inner ear, increased the sound pressure level and resulted in labyrinthitis with severe inflammation. Immunohistochemistry detected GPCMV-infected cells mainly in the scala tympani, scala vestibule and spinal ganglion, but rarely in the cochlear duct. Injection of GPCMV to 5-week pregnant guinea pigs resulted in severe labyrinthitis in fetuses. Immunohistochemistry detected GPCMV-infected cells in the perilymph area and spinal ganglion, but not in the endolymph area, including hair cells. These data suggest that the virus spreads via the perilymph and neural routes in the inner ear of both models of direct and congenital infections.


Asunto(s)
Laberintitis/virología , Infecciones por Roseolovirus/virología , Roseolovirus/fisiología , Animales , Conducto Coclear/virología , Modelos Animales de Enfermedad , Endolinfa/virología , Ganglios Espinales/virología , Cobayas , Inmunohistoquímica , Inflamación/patología , Laberintitis/patología , Perilinfa/virología , Infecciones por Roseolovirus/patología , Rampa Timpánica/virología
18.
Antimicrob Agents Chemother ; 50(9): 3142-5, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16940113

RESUMEN

To simplify the titration of infectious varicella-zoster virus (VZV), we generated a reporter cell line that produced luciferase in a dose-dependent manner upon infection with cell-free VZV. A few VZV-infected cells were detectable by coculturing with the cell line. We demonstrated the usefulness of the cell line for antiviral studies.


Asunto(s)
Antivirales/farmacología , Línea Celular/enzimología , Línea Celular/virología , Herpesvirus Humano 3/genética , Pruebas de Sensibilidad Microbiana/métodos , Secuencia de Bases , Genes Reporteros/genética , Herpesvirus Humano 3/efectos de los fármacos , Luciferasas/biosíntesis , Luciferasas/genética , Datos de Secuencia Molecular , Sistemas de Lectura Abierta , Regiones Promotoras Genéticas
19.
Circ J ; 70(6): 750-5, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16723798

RESUMEN

BACKGROUND: The significance of inverted T waves remains unclear in patients with acute pulmonary embolism (PE). METHODS AND RESULTS: The relationship of the number of leads with inverted T waves to the severity of PE in 40 patients with acute PE was studied. Patients were classified into 3 groups according to the number of leads with inverted T waves on the admission electrocardiogram (ECG): 15 patients, or=7 leads (group H). In groups L, M and H, the rates of right ventricular dysfunction on echocardiography were 47%, 92% and 100% (p<0.01), respectively, and the rates of in-hospital complicated events (including death or the need for catecholamine support, cardiopulmonary resuscitation or mechanical cardiovascular support because of hemodynamic instability) were 0%, 8% and 46% (p=0.004), respectively. On multivariate analysis, arterial hypotension at presentation (odds ratio (OR) 8.96, p=0.049) and inverted T waves in >or=7 leads on the admission ECG (OR 16.8, p=0.037) were the only independent predictors of in-hospital complicated events. CONCLUSIONS: The number of leads with inverted T waves may be a useful and simple marker of increased risk for early complications in patients with acute PE.


Asunto(s)
Electrocardiografía , Embolia Pulmonar/fisiopatología , Enfermedad Aguda , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipertensión/complicaciones , Hipertensión/fisiopatología , Hipertensión/terapia , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Pronóstico , Embolia Pulmonar/complicaciones , Embolia Pulmonar/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA